StockNews.com upgraded shares of FONAR (NASDAQ:FONR - Free Report) from a buy rating to a strong-buy rating in a research note released on Friday morning.
FONAR Trading Down 0.7 %
FONAR stock traded down $0.10 during mid-day trading on Friday, reaching $15.03. The company's stock had a trading volume of 14,136 shares, compared to its average volume of 17,820. The firm has a market cap of $95.11 million, a price-to-earnings ratio of 9.82 and a beta of 1.19. FONAR has a twelve month low of $13.47 and a twelve month high of $24.05. The business has a 50 day moving average price of $16.11 and a 200-day moving average price of $16.33.
FONAR (NASDAQ:FONR - Get Free Report) last announced its quarterly earnings data on Friday, September 27th. The medical equipment provider reported $0.13 earnings per share for the quarter. The business had revenue of $25.94 million during the quarter. FONAR had a net margin of 10.27% and a return on equity of 6.77%.
Institutional Investors Weigh In On FONAR
Large investors have recently added to or reduced their stakes in the stock. Inspire Advisors LLC bought a new position in shares of FONAR during the first quarter worth about $218,000. Lakewood Asset Management LLC acquired a new stake in shares of FONAR in the third quarter valued at approximately $173,000. Empowered Funds LLC raised its holdings in shares of FONAR by 37.6% during the first quarter. Empowered Funds LLC now owns 16,492 shares of the medical equipment provider's stock valued at $352,000 after buying an additional 4,507 shares during the last quarter. Linden Thomas Advisory Services LLC raised its holdings in shares of FONAR by 9.6% during the second quarter. Linden Thomas Advisory Services LLC now owns 21,605 shares of the medical equipment provider's stock valued at $346,000 after buying an additional 1,900 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC grew its holdings in FONAR by 38.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 32,978 shares of the medical equipment provider's stock worth $704,000 after buying an additional 9,237 shares in the last quarter. 50.64% of the stock is owned by institutional investors and hedge funds.
About FONAR
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Featured Articles
Before you consider FONAR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FONAR wasn't on the list.
While FONAR currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.